BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25401297)

  • 21. Philadelphia-positive acute lymphoblastic leukemia with multiple subclones including duplication of the Philadelphia chromosome and Abelson oncogene.
    La Starza R; Vitale A; Serra A; Saglio G; Fioritoni G; Falzetti D; Martelli MF; Foà R; Mecucci C
    Cancer Genet Cytogenet; 2002 Jan; 132(1):46-50. PubMed ID: 11801308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16).
    Dai HP; Xue YQ; Wu LL; Pan JL; Gong YL; Wu YF; Zhang J; Wu DP; Chen SN
    Int J Hematol; 2012 Dec; 96(6):814-7. PubMed ID: 23054652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatment.
    Yogarajah M; Montgomery N; Matson M; Blanchard L; Frank C; Gallagher S; Pepin K; Vaught L; Muluneh B; Foster MC; Zeidner JF
    Leuk Lymphoma; 2018 Dec; 59(12):3010-3012. PubMed ID: 29749763
    [No Abstract]   [Full Text] [Related]  

  • 24. A de novo philadelphia chromosome-positive acute mixed-lineage leukemia with both major and minor BCR/ABL mRNA transcripts.
    Tarumoto T; Imagawa S; Ohmine K; Mano A; Nagai T; Takatoku M; Muroi K; Hatake K; Ozawa K
    Am J Hematol; 2000 Sep; 65(1):72-4. PubMed ID: 10936868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary Philadelphia chromosome and erythrophagocytosis in a relapsed acute myeloid leukemia after hematopoietic cell transplantation.
    Kelemen K; Galani K; Conley CR; Greipp PT
    Cancer Genet; 2014 Jun; 207(6):268-71. PubMed ID: 25074248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful Use of Nilotinib in the Therapy of a Patient with a Chemoresistant Relapse of BCR-ABL1-Like Phenotype Acute Lymphoblastic Leukemia.
    Piekarska A; Sadowska-Klasa A; Libura M; Karabin K; Hellmann A
    Oncol Res Treat; 2018; 41(9):550-553. PubMed ID: 30121665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.
    Kawajiri C; Tanaka H; Hashimoto S; Takeda Y; Sakai S; Takagi T; Takeuchi M; Ohwada C; Sakaida E; Shimizu N; Nakaseko C
    Int J Hematol; 2014 Apr; 99(4):513-8. PubMed ID: 24532437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
    Saydam G; Haznedaroglu IC; Kaynar L; Yavuz AS; Ali R; Guvenc B; Akay OM; Baslar Z; Ozbek U; Sonmez M; Aydin D; Pehlivan M; Undar B; Dagdas S; Ayyildiz O; Akkaynak DZ; Dag IM; Ilhan O
    Expert Opin Pharmacother; 2016 Oct; 17(14):1851-8. PubMed ID: 27501474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
    Ahmed IO; Ochogwu LO; Owojuyigbe TO; Akinola NO; Durosinmi MA
    J Med Case Rep; 2021 Oct; 15(1):504. PubMed ID: 34625105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient.
    Chen L; Wu Y; You Y; Xiao M; Yao Y; Li W
    Leuk Lymphoma; 2016 Dec; 57(12):2930-2933. PubMed ID: 27118564
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of dasatinib in accelerated-phase chronic myeloid leukemia with p190 BCR-ABL1 and a second Philadelphia chromosome.
    Rabenau KE; Dolan M; Yohe S; Ustun C
    Cancer Genet; 2014 Mar; 207(3):109-10. PubMed ID: 24703333
    [No Abstract]   [Full Text] [Related]  

  • 33. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
    Akashi K; Taniguchi S; Nagafuji K; Harada M; Shibuya T; Hayashi S; Gondo H; Niho Y
    Leuk Res; 1993 Jul; 17(7):549-55. PubMed ID: 8326735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-appearing Philadelphia chromosome in childhood acute myeloid leukemia.
    Shah N; Leaker MT; Teshima I; Baruchel S; Abdelhaleem M; Ye CC
    Pediatr Blood Cancer; 2008 May; 50(5):1052-3. PubMed ID: 18213712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL) and inversion 16 (CBFB-MYH11): report of two cases and review of the literature.
    Roth CG; Contis L; Gupta S; Agha M; Safyan E
    Leuk Lymphoma; 2011 Mar; 52(3):531-5. PubMed ID: 21281226
    [No Abstract]   [Full Text] [Related]  

  • 36. Late appearance of a Philadelphia translocation with minor-BCR/ABL transcript in a t(7;11)(p15;p15) acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Fujimura T; Kodama A; Miyazawa K; Aizawa S; Toyama K
    Leukemia; 1995 Apr; 9(4):640-2. PubMed ID: 7723398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib.
    Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Larráyoz MJ; Lahortiga I; Andreu EJ; Márquez J; Beltrán de Heredia JM; Odero MD; Prósper F; Calasanz MJ
    Cancer Genet Cytogenet; 2005 Jul; 160(1):22-6. PubMed ID: 15949566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome.
    Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Murakami N; Miura O
    Rinsho Ketsueki; 2003 Apr; 44(4):242-8. PubMed ID: 12784657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCR-ABL rearrangement and 'variant' Philadelphia chromosome in de novo acute myelogenous leukaemia FAB subtype M1.
    Cigudosa JC; Acosta Almeida MT; Carrasco V; Bello T; Carrasco JL; Otero Gómez A; Garcia Talavera J; García Miranda JL
    Br J Haematol; 1995 Dec; 91(4):932-4. PubMed ID: 8547143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and significance of the Philadelphia negative/
    Ratajczak B; Gniot M; Przybylowicz-Chalecka A; Czerwinska-Rybak J; Komarnicki M; Lewandowski K; Jarmuz-Szymczak M
    Leuk Lymphoma; 2020 Jan; 61(1):189-193. PubMed ID: 31389273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.